ANI Pharmaceuticals

ANI Pharmaceuticals
Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
About
What does ANI Pharmaceuticals do?
ANI Pharmaceuticals is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics. Their strategic focus is on transforming into a leading Rare Disease company, while also maintaining a Generics and Established Brands business. They offer a range of prescription pharmaceutical products.
What is ANI Pharmaceuticals's revenue?
StartupHub estimates ANI Pharmaceuticals's annual revenue at $91.2M (range $50.3M to $169.1M, 66% confidence), based on comparable companies in the sector.
What is ANI Pharmaceuticals's valuation?
StartupHub estimates ANI Pharmaceuticals's effective valuation at $2.7B (range $1.7B to $4.0B, 14% confidence), based on comparable companies in the sector.
How much funding has ANI Pharmaceuticals raised?
ANI Pharmaceuticals has raised a total of $671M in funding. The most recent round on record is Acquisition.
Where is ANI Pharmaceuticals headquartered?
ANI Pharmaceuticals is headquartered in Baudette, United States.
When was ANI Pharmaceuticals founded?
ANI Pharmaceuticals was founded in 1996.
What industry does ANI Pharmaceuticals operate in?
ANI Pharmaceuticals operates in Biotech, Pharmaceuticals, Rare Disease, Generics, Drug Discovery, Manufacturing.
How many employees does ANI Pharmaceuticals have?
ANI Pharmaceuticals has approximately 707 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.